Mechanisms of Immunosurveillance for Lung Cancer
Mechanisms of Immunosurveillance for Lung Cancer
批准号:
8974355
负责人:
ALEXANDER S. KRUPNICK
金额:
$0.0万
依托单位国家:
美国
项目类别:
财政年份:
2014
资助国家:
美国
项目状态:
已结题
起止时间:
2014-01-01 至 2017-12-31
关键词:
Adjuvant TherapyAdoptive TransferAdultAnimal ModelAnimalsApplications GrantsAtypical lymphocyteCause of DeathCellsChromosomes, Human, Pair 19Chromosomes, Human, Pair 6Clinical TrialsDefectDevelopmentDiseaseDisease ResistanceEtiologyGenetic PolymorphismGoalsGrowthGrowth and Development functionHealthHistocompatibility Antigens Class IHumanImmuneImmune System DiseasesImmune systemImmunoglobulinsImmunologic MonitoringImmunologicsImmunotherapyIn VitroIndividualIndividual DifferencesInheritedKiller CellsLicensingLigandsLigationMHC Class I GenesMalignant - descriptorMalignant NeoplasmsMalignant neoplasm of lungMalignant neoplasm of prostateMediatingMethodsMouse StrainsMusMutateNK Cell ActivationNatural Killer CellsNon-Small-Cell Lung CarcinomaPlayPopulationPredispositionProcessProstateProteinsProtocols documentationRecording of previous eventsResistanceRoleShapesSmokingSolid NeoplasmT-LymphocyteTechnologyTestingTumor AngiogenesisTumor AntigensVaccinationVariantWestern WorldZinc Fingersadaptive immunityarmbasecancer immunotherapycytotoxiccytotoxicityendonucleasefibrosarcomaimmunogenicityimprovedin vivokidney cellmanmelanomamouse modelpre-clinicalreceptortranslational clinical trialtumor
中文摘要
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant):
Lung cancer remains the major cancer-related cause of death in the Western World and intense efforts are directed toward the development of adjuvant therapy for the treatment of this disease. While immunotherapy targeting the adaptive immune response in the form of T lymphocytes has been successful for several solid tumors, such as melanoma and prostate cancer, it has been extremely unsuccessful in lung cancer. We have recently discovered that, unlike other solid tumors, the innate rather than adaptive immune system plays a critical role in immunosurveillance for lung cancer. Furthermore, individual differences in natural killer cells (NK cells) play a role in susceptibility or resistance to this disease. In this proposal we focus o the role of natural killer cells in immunosurveillance and immunotherapy of lung cancer. We plan to explore mechanistic aspects of lung cancer immunosurveillance in a mouse model and will evaluate the immunologic basis of human susceptibility to this disease. In the first aim we will study the role of the activating receptor NKp46 in lung cancer-specific activation of NK cells. In the second aim we will evaluate the mechanisms used by NK cells to control lung cancer in vivo and in the third aim we will focus on the inhibitory receptor Ly49C as it relates to strain-specifi differences in anti-cancer activity of NK cells. In the fourth and final aim we plan to evaluate th licensing status of human NK cells and susceptibility to lung cancer. 1
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Inflammatory Cellular Mechanisms for Establishing and Maintaining Lung Allograft Tolerance
-
批准号:10024445
-
项目类别:
-
资助金额:$49.81万
-
财政年份:2015
-
负责人:ALEXANDER S. KRUPNICK
-
依托单位:
Inflammatory Cellular Mechanisms for Establishing and Maintaining Lung Allograft Tolerance
-
批准号:10625537
-
项目类别:
-
资助金额:$44.95万
-
财政年份:2015
-
负责人:ALEXANDER S. KRUPNICK
-
依托单位:
Inflammatory Cellular Mechanisms for Establishing and Maintaining Lung Allograft Tolerance
-
批准号:10197018
-
项目类别:
-
资助金额:$47.39万
-
财政年份:2015
-
负责人:ALEXANDER S. KRUPNICK
-
依托单位:
Inflammatory Cellular Mechanisms for Establishing and Maintaining Lung Allograft Tolerance
-
批准号:10619068
-
项目类别:
-
资助金额:$45.46万
-
财政年份:2015
-
负责人:ALEXANDER S. KRUPNICK
-
依托单位:
Mechanisms of Immunosurveillance for Lung Cancer-the Role of CD8+ T Cells in Tumor Tolerance Induction
-
批准号:10512744
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2014
-
负责人:ALEXANDER S. KRUPNICK
-
依托单位:
Mechanisms of Immunosurveillance for Lung Cancer
-
批准号:9280818
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2014
-
负责人:ALEXANDER S. KRUPNICK
-
依托单位:
Mechanisms of Immunosurveillance for Lung Cancer-the Role of CD8+ T Cells in Tumor Tolerance Induction
-
批准号:10255913
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2014
-
负责人:ALEXANDER S. KRUPNICK
-
依托单位:
Mechanisms of Immunosurveillance for Lung Cancer
-
批准号:8629870
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2014
-
负责人:ALEXANDER S. KRUPNICK
-
依托单位:
MECHANISMS OF LUNG ALLOGRAFT ACCEPTANCE
-
批准号:8847372
-
项目类别:
-
资助金额:$37.43万
-
财政年份:2012
-
负责人:ALEXANDER S. KRUPNICK
-
依托单位:
MECHANISMS OF LUNG ALLOGRAFT ACCEPTANCE
-
批准号:8669146
-
项目类别:
-
资助金额:$37.24万
-
财政年份:2012
-
负责人:ALEXANDER S. KRUPNICK
-
依托单位:
MECHANISMS OF LUNG ALLOGRAFT ACCEPTANCE
-
批准号:8372581
-
项目类别:
-
资助金额:$38.0万
-
财政年份:2012
-
负责人:ALEXANDER S. KRUPNICK
-
依托单位:
MECHANISMS OF LUNG ALLOGRAFT ACCEPTANCE
-
批准号:8530273
-
项目类别:
-
资助金额:$36.18万
-
财政年份:2012
-
负责人:ALEXANDER S. KRUPNICK
-
依托单位:
The Role of Non-Hematopoietic Cells in Tumor Tolerance Induction
-
批准号:7920564
-
项目类别:
-
资助金额:$10.8万
-
财政年份:2009
-
负责人:ALEXANDER S. KRUPNICK
-
依托单位:
The Role of Non-Hematopoietic Cells in Tumor Tolerance Induction
-
批准号:8116998
-
项目类别:
-
资助金额:$12.06万
-
财政年份:2008
-
负责人:ALEXANDER S. KRUPNICK
-
依托单位:
The Role of Non-Hematopoietic Cells in Tumor Tolerance Induction
-
批准号:7686139
-
项目类别:
-
资助金额:$12.06万
-
财政年份:2008
-
负责人:ALEXANDER S. KRUPNICK
-
依托单位:
The Role of Non-Hematopoietic Cells in Tumor Tolerance Induction
-
批准号:8323951
-
项目类别:
-
资助金额:$11.99万
-
财政年份:2008
-
负责人:ALEXANDER S. KRUPNICK
-
依托单位:
The Role of Non-Hematopoietic Cells in Tumor Tolerance Induction
-
批准号:7906933
-
项目类别:
-
资助金额:$12.06万
-
财政年份:2008
-
负责人:ALEXANDER S. KRUPNICK
-
依托单位:
The Role of Non-Hematopoietic Cells in Tumor Tolerance Induction
-
批准号:7356202
-
项目类别:
-
资助金额:$12.06万
-
财政年份:2008
-
负责人:ALEXANDER S. KRUPNICK
-
依托单位:
TISSUE ENGINEERING FOR DIAPHRAGMATIC RECONSTRUCTION
-
批准号:6388740
-
项目类别:
-
资助金额:$4.56万
-
财政年份:2001
-
负责人:ALEXANDER S. KRUPNICK
-
依托单位:
TISSUE ENGINEERING FOR DIAPHRAGMATIC RECONSTRUCTION
-
批准号:6183096
-
项目类别:
-
资助金额:$4.09万
-
财政年份:2000
-
负责人:ALEXANDER S. KRUPNICK
-
依托单位:
海外基金